Market revenue in 2023 | USD 12.8 million |
Market revenue in 2030 | USD 25.0 million |
Growth rate | 10.1% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-House, Outsourcing |
Key market players worldwide | Steris PLC, Sotera Health Co Ordinary Shares, Sartorius AG, Solvias, SGS AG, Labcorp Holdings Inc, Pace Analytical Services, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc Class A, Almac Group, Pacific BioLabs, Inc., Boston Analytical, Labor LS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical sterility testing market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 59.38% in 2023. Horizon Databook has segmented the Mexico pharmaceutical sterility testing market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico is considered a significant offshoring and outsourcing country in Latin America, along with Brazil and Argentina, due to the partnership of the Central American Free Trade Agreement (CAFTA-DR) with the U.S. In addition, local & foreign investors are investing in the market due to recent economic growth and healthy government policies.
The pharmaceutical companies are focusing on the Mexico market to obtain key services at cost-effective prices (lower-cost operations).
Moreover, Mexico has strong Intellectual Property (IP) systems, attracting foreign companies to invest in Mexico due to reduced obstacles in enforcing IP rights and proper management and protection of IP. Furthermore, Mexico is a hub for clinical trial outsourcing due to the significant savings in drug development costs.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico pharmaceutical sterility testing market , including forecasts for subscribers. This country databook contains high-level insights into Mexico pharmaceutical sterility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account